Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
International Journal of Hematology
Published in: International Journal of Hematology 4/2015

01-04-2015 | Images in Hematology

Massive splenic hamartoma with bizarre stromal cells

Authors: Nuri Yigit, Shannon Covey, Wayne Tam

Published in: International Journal of Hematology | Issue 4/2015

Login to get access

Excerpt

A 35-year-old female with history of sickle cell trait presented to the emergency room with chest pain and pelvic pressure. Blood test showed pancytopenia. She had already undergone a bone marrow biopsy, which was found with a norm cellular marrow with increased megakaryocytes. Computed tomography scan with contrast revealed massive splenomegaly, secondary to a heterogeneously hypo enhancing solitary lesion with multiple relatively hypo dense striations, measuring up to 24.5 × 13.6 × 13.0 cm. Differential included mainly hamartoma and lymphoma, with other benign and malignant entities considered less likely. …
Literature
1.
Serra S, Chetty R. Bizarre stromal cells in ischemic bowel disease. Ann Diagn Pathol. 2005;9(4):193–6.CrossRefPubMed
Metadata
Title
Massive splenic hamartoma with bizarre stromal cells
Authors
Nuri Yigit
Shannon Covey
Wayne Tam
Publication date
01-04-2015
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 4/2015
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-015-1748-6

Other articles of this Issue 4/2015

International Journal of Hematology 4/2015 Go to the issue

Progress in Hematology

The RUNX1–PU.1 axis in the control of hematopoiesis

Original Article

Clinical significance of IPF% or RP% measurement in distinguishing primary immune thrombocytopenia from aplastic thrombocytopenic disorders

Progress in Hematology

C/EBPα in normal and malignant myelopoiesis

Original Article

Reactivation of hepatitis B virus (HBV) infection in adult T-cell leukemia–lymphoma patients with resolved HBV infection following systemic chemotherapy

Case Report

Bleeding complications after arthroscopy in a JAK2V617F-positive patient with essential thrombocythemia and acquired von Willebrand syndrome (AVWS)

Case Report

Identification of a homozygous JAK3 V674A mutation caused by acquired uniparental disomy in a relapsed early T-cell precursor ALL patient
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits